MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

New XK deletion associated with McLeod syndrome

A. DoedeMaindreville, G. Jouret, E. Landais, P. Feucher, S. Bakchine, D. Gaillard, A.S. Lebre (Reims, France)

Meeting: 2017 International Congress

Abstract Number: 825

Keywords: Acanthocytosis

Session Information

Date: Wednesday, June 7, 2017

Session Title: Choreas (Non-Huntington’s Disease)

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To describe a new XK deletion associated with McLeod syndrome.

Background: McLeod syndrome is a rare genetic syndrome characterized by the association of chorea and acanthocytosis. This syndrome is an X-linked disease caused by hemizygous mutation or deletion in XK gene. To date, 37 disease-causing variants in the XK gene have been reported, including 26 mutations and 11 chromosome Xp21 deletions.

Methods: A 58-years old man without familial history was admitted in our Neurology Department for progressive chorea. He presented with diffuse chorea without facial involvement and a moderate dysarthria. His family noticed a recent irritability. Brain MRI revealed a bilateral and symmetrical frontal ventricular corn dilatation. Neuropsychological evaluation showed a moderate dysexecutive syndrome.

Results: Genetic analysis revealed absence of HTT gene expansion and VPC13A gene mutation. On biological examination, patient presented with acanthocytosis, elevated blood CPK and Kell antigen negative. Molecular studies including PCR and array CGH study allowed us to identify a new 3Mb deletion in Xp21 chromosome and diagnose a McLeod syndrome in our patient. Interestingly, the patient did not present with cardiac disorder. On electromyography, an asymptomatic axonal sensitive and motor polyneuropathy was observed.

Conclusions: McLeod syndrome is a rare X-linked chorea associated with acanthocytosis. To date, only 12 chromosome Xp21 deletions (including this case) has been identified. 4/12 deletions were clinically characterized by Xp21 contiguous gene syndrome with a deletion of multiple gene loci that are adjacent to XK gene, as DMD (Duchenne and Becker muscular dystrophy), CYBB (X-linked chronic granulomatous disease) and/or RPGR (Retinitis pigmentosa-3) genes. Molecular studies for McLeod syndrome were set up in our hospital allowing familial study and genetic counselling to the family of our patient.

 

References: Mengfatt Ho, Jamel Chelly, Nick Carter, Adrian Danek, Paul Crocker, Anthony P. Monaco. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cel. 1994. 77: 869-80.

To cite this abstract in AMA style:

A. DoedeMaindreville, G. Jouret, E. Landais, P. Feucher, S. Bakchine, D. Gaillard, A.S. Lebre. New XK deletion associated with McLeod syndrome [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/new-xk-deletion-associated-with-mcleod-syndrome/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/new-xk-deletion-associated-with-mcleod-syndrome/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley